Abnormal ERG responses have been reported in 78.2–92% of PRPH2 retinopathy patients [34,40], and cone and rod dysfunction has been reported in 50–68% of patients with a PSPD phenotype [40,66]. This evidence concerns the gene PRPH2 and retinal disorder.